This content is machine translated Type 1 diabetes Despite known cardiac risk, many patients are undertreated Cardiac problems such as coronary artery disease and heart failure are among the most common and dangerous complications of type 1 diabetes. The mortality risk is significantly increased. Although this…
View Post 3 min This content is machine translated Hyperkalemia How the Guideline Comes to the Bedside: Hyperkalemia Management Up to Date Patients with chronic heart or kidney failure often suffer from hyperkalemia. The use of RAAS inhibitors in particular may increase the risk of this life-threatening electrolyte disturbance. Therefore, therapy of…
View Post 7 min This content is machine translated Supraventricular tachycardias ECG interpretation in SVT Supraventricular tachycardia (SVT) occurs in the general population with a prevalence of approximately 2-3/1000 population. Many people can be helped by adequate diagnosis and treatment of arrhythmias, and the correct…
View Post 3 min This content is machine translated Heart failure Empagliflozin Reduces Risk of Cardiovascular Death and Hospitalization Rate in Heart Failure Ingelheim, Germany and Indianapolis, USA – Results from the phase III EMPEROR-Reduced study in adults with heart failure with reduced ejection fraction (with and without diabetes) showed that empagliflozin was…
View Post 2 min This content is machine translated Atrial fibrillation Early rhythm control aims for better outcomes In patients with newly diagnosed AF, early initiation of rhythm control may reduce cardiovascular outcomes. Therapy with antiarrhythmic drugs and/or catheter ablation reduced cardiovascular deaths, strokes, and hospitalizations caused by…
View Post 4 min This content is machine translated Primary prevention of atherosclerosis Non-HDL cholesterol associated with long-term risk The criteria for cardiovascular risk stratification defined in the current guidelines of the European Society of Cardiology (ESC) form the basis for the calculation of an individual risk score. Non-HDL…
View Post 3 min This content is machine translated Alzheimer's and Co. Effective blood pressure therapy keeps dementia risk in check Dementia is an expression and consequence of various diseases. Due to demographic change, the prevalence is steadily increasing. A few years ago, it was possible to uncover a link between…
View Post 3 min This content is machine translated Diabetes Therapy Do GLP-1 receptor agonists contribute to stroke prophylaxis? The risk of suffering a stroke is massively higher for diabetics than in the general population. New data suggest that dulaglutide reduces the risk of ischemic stroke in diabetic patients…
View Post 4 min This content is machine translated Diabetes mellitus type 2 New Swiss guidelines support cardiovascular disease control The treatment of type 2 diabetes mellitus has undergone a transformation in recent years with the approval of new drug classes. The focus is no longer on pure glycemic control,…
View Post 5 min This content is machine translated Chronic coronary syndrome Risk stratification in coronary artery disease – an update. Coronary CT is highly ranked for the work-up algorithm in the updated European Society of Cardiology (ESC) guidelines. Calcification is an important prognostic indicator and has therapeutic implications. Among other…
View Post 6 min This content is machine translated COPD therapy Biomarkers could facilitate many things 22-40% of all COPD patients experience at least one moderate or severe exacerbation annually. Patients with frequent exacerbations have a worse prognosis. A team of researchers has been looking at…
